RD532 - Substance Abuse Services Council Report on Treatment Programs for FY 2020 – December 1, 2020
This report summarizes information from the three executive branch agencies that provide substance abuse treatment services: The Department of Behavioral Health and Developmental Services (DBHDS), the Department of Juvenile Justice (DJJ), and the Department of Corrections (DOC). These agencies share the common goals of increasing abstinence from alcohol and other drug use and reducing criminal behavior. All of the agencies included in this report are invested in providing evidenced-based treatment to their populations within the specific constraints each has on its ability to provide effective treatment services. In this report, the following information is detailed concerning each of these three agencies’ substance abuse treatment programs:
1. Amount of funding spent for the program in FY 2020;
As used in this document, treatment means those services directed toward individuals with identified substance misuse or dependence disorders and does not include prevention services. This report provides information for Fiscal Year 2020, which covers the period from July 1, 2019 through June 30, 2020.
Treatment Programs for FY 2020
This report provides focused data on specific outcomes. Every opioid overdose death represents many affected individuals (see Figure 1), and every individual who commits a crime associated with substance misuse represents many others who are also involved. Many of these individuals are struggling with functional impairment, and this is reflected in decreased workforce participation,(*1) negative impact on the economy,(*2) the potential for explosive dissemination of blood-borne diseases,(*3) and recidivism.
While we are thankful for the inclusion of Methamphetamine treatment in the monies allocated for 2020, it should be noted that singling out specific substances such as opioids, methamphetamines, or other “unfunded" substances fails to recognize the disease of addiction as being non-substance specific. In turn, this leads to “chasing" a particular drug, similar to squeezing a balloon – if it gets small on one end, it will get bigger on the other. This results in duplicated services, wasted money, and poor outcomes.